Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AFRM
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio -70.22 14.54 48.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 213.50 289.33 -92.29
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value -2.04 8.39 8.57
Cash 9.29 6.93 6.34
Capex -18.01 -0.15 -0.13
Free Cash Flow 347.13 0.52 0.12
Revenue -4.11 1.84 1.92
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin 31.37 0.85 0.64
Operating Margin 87.49 -0.04 -0.29
ROA 20.94 -0.01 -0.02
ROE 19.40 -0.05 -0.06
ROIC 87.64 < 0.005 -0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AFRM is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AFRM is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AFRM is permitted for members.